Mar 17, 2026 by Danny Vena, CPANvidia Stock Investors Just Got Fantastic From the Trump AdministrationA proposed rule that would have marked a major setback for the AI chipmaker has been shelved.
Mar 17, 2026 by Matt DiLalloThe Stock Prices of These 3 Oil Giants Are Up Roughly 30% in 2026. But Are They a Buy?These top oil stocks don't need high oil prices to thrive.
Mar 17, 2026 by Dan CaplingerYour ETF Could Have a Fatal Flaw. Here's the AnswerSometimes the best solutions are also the simplest.
Mar 17, 2026 by Matt DiLalloThe Stock Prices of These 3 Oil Giants Are Up Roughly 30% in 2026. But Are They a Buy?These top oil stocks don't need high oil prices to thrive.
Mar 17, 2026 by James BrumleyWhy Lemonade Stock Is Up More Than 15% on TuesdayAnalysts are beginning to appreciate the potential of using technology to support an insurance business in a rapidly evolving marketplace.
Mar 17, 2026 by Dan CaplingerYour ETF Could Have a Fatal Flaw. Here's the AnswerSometimes the best solutions are also the simplest.
Mar 17, 2026 by David Jagielski, CPAThis Rock-Solid Dividend Stock Yields More Than 5% and Is Known for Its StabilityEnbridge is a big player in the oil and gas industry, and it's been a top dividend growth stock for decades.
Mar 17, 2026 by David Jagielski, CPACould Nebius Stock Be a 10X Investment?Nebius is a red-hot tech stock that has experienced a significant surge in demand due to artificial intelligence.
Mar 17, 2026 by David Jagielski, CPAIs a Reverse Stock Split Inevitable for Beyond Meat?The company recently received a warning letter from the Nasdaq.
Mar 17, 2026 by Jason Hall and Tyler CroweThe Best Dividend Stocks to Buy and Hold ForeverBoth are built to generate steady cash flows and grow their payouts to shareholders for many years to come.
Mar 17, 2026 by Patrick SandersThe Best Warren Buffett Stocks to Buy With $900 Right NowUse fractional shares to put $100 on each of these companies.
Mar 17, 2026 by Rich SmithWhy Six Flags Entertainment Stock Just PoppedSix Flags has a choice to make: Keep working toward an uncertain turnaround, or just sell?
Mar 17, 2026 by Jake LerchISCG vs. VBK: Which ETF Offers Lower Fees, More Liquidity, and Greater Returns?Portfolio breadth, sector mix, and subtle cost differences set these small-cap growth ETFs apart for investors weighing their next move.
Mar 17, 2026 by Matt DiLalloThese 3 Top Financial Stocks Are Down As Much As 43.5% on Private Credit Fears. Here's Why I'm Buying Them Like There's No Tomorrow.These financial firms are the best of the best at what they do.
Mar 17, 2026 by Danny Vena, CPANvidia Stock Investors Just Got Fantastic From the Trump AdministrationA proposed rule that would have marked a major setback for the AI chipmaker has been shelved.
Mar 17, 2026 by Reuben Gregg Brewer2 Dividend Stocks to Double Up on Right NowOne is in the middle of a turnaround, and the other is an energy stock that sidesteps commodity risk.
Mar 17, 2026 by John Bromels3 Artificial Intelligence (AI) Stocks Set to Dominate the Next DecadeEach of these major AI players looks poised for long-term success.
Mar 17, 2026 by Dave KovaleskiThe Single Best Way to Invest $500 in Artificial Intelligence (AI) Right NowA themed ETF is the way to go to tap into the best AI stocks.
Mar 17, 2026 by Jennifer SaibilThe Market Hasn't Moved This Year. Should Investors Be Worried?It's starting to turn south.
Mar 17, 2026 by Jake LerchSmall-Cap ETFs: ISCG Boasts Lower Fees and Better Recent Performance, but SLYG Has Greater Liquidity and a Lower Risk ProfileExpense ratios, portfolio breadth, and sector tilts set these small-cap ETFs apart—see how their differences may shape your strategy.
Mar 17, 2026 by Ryan VanzoWhere Will Lucid Group Be in 3 Years?Lucid Group has big dreams for the future. Will they become reality?
Mar 17, 2026 by Manali Pradhan, CFA2 Artificial Intelligence (AI) Networking Stocks With the Highest Upside in 2026As AI data centers grow larger and more complex, these two AI networking stocks seem well positioned to surge in 2026.
Mar 17, 2026 by David Jagielski, CPAThis Promising GLP-1 Drug Could Give Novo Nordisk Investors Renewed Hope for the StockNovo Nordisk recently announced promising trial results for one of its GLP-1 drugs in development.
